Delivery Order SPE2DB20D3101-SPE2DB25FRWQ4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,487.60 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml cartridges on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract represents a non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Imitrex is a migraine treatment medication, and this delivery order fulfills specific pharmaceutical supply needs for federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,107.71 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on August 18, 2025, with a completion date of August 19, 2025. This firm fixed price delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs, specifically supporting military and veteran healthcare systems. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $5,869.17 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Imitrex (sumatriptan) is a prescription medication used to treat migraine headaches, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges totaling $15,182.55 with completion expected by May 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $14,682.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL cartridges (0.5 mL), with an ultimate completion date of August 1, 2025. This non-set-aside contract was competitively awarded on July 31, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges totaling $1,519.07 with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges (0.5 ml) under a firm fixed price contract valued at $1,819.68. The contract carries an ultimate completion date of June 3, 2025, and represents a non-competitive, non-set-aside award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges with a contract ceiling value of $3,639.24. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The contract is set to conclude on September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges with a ceiling value of $7,278.48. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order is due for completion by June 6, 2025, reflecting the expedited nature of pharmaceutical procurement...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564179980 IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML. The $3,081.87 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical and medical supplies to DLA Troop Support Medical facilities in support of military treatment programs...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWQ4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,318.59 to AmerisourceBergen Drug Corp for IMITREX 6 mg/0.5 mL cartridges on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. IMITREX (sumatriptan) is a prescription medication used to treat acute migraine headaches, and this order fulfills pharmaceutical supply needs within the federal medical procurement system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's status as a prime contractor under this comprehensive global pharmaceutical support vehicle demonstrates its capability to meet federal medical supply requirements through open competition and positions it to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/26/25 |